Jeff Aronin

1 POSTS 0 COMMENTS
Jeff Aronin is chairman and CEO of Paragon Biosciences, which, along with partners, has invested approximately $1 billion in portfolio companies since 2017 and expects ongoing investments of up to $500 million annually.

How One CEO Is Changing Life Sciences Innovation

Using a unique company incubator approach, Paragon Biosciences boasts an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
- Advertisement -
- Advertisement -

FEATURED CONTENT

New Poll: CEOs Find Challenges In Using Customer Data To Drive Innovation

Ability to harness and sort through data for meaningful insights remains a hurdle, many say. “The key is...finding what is actually relevant.”

SUBSCRIBE TO CHIEF EXECUTIVE

Sign Up to Receive Chief Executive Magazine

Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.

CEO CONFIDENCE INDEX

CEO Optimism Falls To 12-Month Low In October

Chief Executive’s latest reading of CEO sentiment shows growing number of CEOs disillusioned with short-term economic recovery, as list of issues disrupting business continues to grow.